News

Featured News

  • 2024 |
  • 2023 |
  • 2022 |
  • 2021 |
  • 2020 |
  • 2019 |
  • 2018 |
  • 2017 |
  • View All
  • News | September 17, 2021

    Skyhawk Therapeutics Completes New Investment Round

    Read More

    News | September 17, 2021

    DICE Therapeutics Announces Pricing of Upsized Initial Public Offering

    Read More

    News | September 17, 2021

    ImCheck Presents Preliminary Patient Response Data from the Phase I/IIa EVICTION Trial with ICT01 at ESMO Congress 2021

    Read More

    News | September 14, 2021

    Bill Haney adds another $133M to Skyhawk’s coffers, as the RNA startup guns for the clinic

    Read More